Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
Izumiya Y, Hanatani S, Kimura Y, Takashio S, Yamamoto E, Kusaka H, Tokitsu T, Rokutanda T, Araki S, Tsujita K, Tanaka T, Yamamuro M, Kojima S, Tayama S, Kaikita K, Hokimoto S, Ogawa H. Izumiya Y, et al. Among authors: yamamuro m. Can J Cardiol. 2014 Mar;30(3):338-44. doi: 10.1016/j.cjca.2013.12.010. Epub 2013 Dec 18. Can J Cardiol. 2014. PMID: 24484911
High serum levels of thrombospondin-2 correlate with poor prognosis of patients with heart failure with preserved ejection fraction.
Kimura Y, Izumiya Y, Hanatani S, Yamamoto E, Kusaka H, Tokitsu T, Takashio S, Sakamoto K, Tsujita K, Tanaka T, Yamamuro M, Kojima S, Tayama S, Kaikita K, Hokimoto S, Ogawa H. Kimura Y, et al. Among authors: yamamuro m. Heart Vessels. 2016 Jan;31(1):52-9. doi: 10.1007/s00380-014-0571-y. Epub 2014 Aug 24. Heart Vessels. 2016. PMID: 25150586
Impact of left ventricular hypertrophy on impaired coronary microvascular dysfunction.
Tsujita K, Yamanaga K, Komura N, Sakamoto K, Miyazaki T, Ishii M, Tabata N, Akasaka T, Sueta D, Arima Y, Kojima S, Yamamoto E, Yamamuro M, Tanaka T, Izumiya Y, Tayama S, Nakamura S, Kaikita K, Hokimoto S, Ogawa H. Tsujita K, et al. Among authors: yamamuro m. Int J Cardiol. 2015;187:411-3. doi: 10.1016/j.ijcard.2015.03.367. Epub 2015 Mar 26. Int J Cardiol. 2015. PMID: 25841137 No abstract available.
Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
Tabata N, Hokimoto S, Akasaka T, Arima Y, Sakamoto K, Yamamoto E, Tsujita K, Izumiya Y, Yamamuro M, Kojima S, Kaikita K, Ogawa H. Tabata N, et al. Among authors: yamamuro m. Heart Vessels. 2016 Jul;31(7):1038-44. doi: 10.1007/s00380-015-0713-x. Epub 2015 Jul 12. Heart Vessels. 2016. PMID: 26164597
Late gadolinium enhancement on cardiac magnetic resonance predicts coronary vasomotor abnormality and myocardial lactate production in patients with chronic heart failure.
Uemura T, Yamamuro M, Kaikita K, Takashio S, Utsunomiya D, Hirakawa K, Nakayama M, Sakamoto K, Yamamoto E, Tsujita K, Kojima S, Hokimoto S, Yamashita Y, Ogawa H. Uemura T, et al. Among authors: yamamuro m. Heart Vessels. 2016 Dec;31(12):1969-1979. doi: 10.1007/s00380-016-0816-z. Epub 2016 Feb 18. Heart Vessels. 2016. PMID: 26892530 Free PMC article.
Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy.
Yamamura S, Izumiya Y, Ishida T, Onoue Y, Kimura Y, Hanatani S, Araki S, Fujisue K, Sueta D, Kanazawa H, Takashio S, Usuku H, Sugamura K, Sakamoto K, Yamamoto E, Yamamuro M, Yasuda H, Kojima S, Kaikita K, Hokimoto S, Ogawa H, Tsujita K. Yamamura S, et al. Among authors: yamamuro m. Heart Vessels. 2017 Jun;32(6):708-713. doi: 10.1007/s00380-016-0925-8. Epub 2016 Nov 23. Heart Vessels. 2017. PMID: 27882404
Late gadolinium enhancement on cardiac magnetic resonance imaging is associated with coronary endothelial dysfunction in patients with dilated cardiomyopathy.
Nakayama M, Yamamuro M, Takashio S, Uemura T, Nakayama N, Hirakawa K, Oda S, Utsunomiya D, Kaikita K, Hokimoto S, Yamashita Y, Morita Y, Kimura K, Tamura K, Tsujita K. Nakayama M, et al. Among authors: yamamuro m. Heart Vessels. 2018 Apr;33(4):393-402. doi: 10.1007/s00380-017-1069-1. Epub 2017 Oct 19. Heart Vessels. 2018. PMID: 29051976
The synergistic combined effect of anemia with high plasma levels of B-type natriuretic peptide significantly predicts an enhanced risk for major adverse cardiac events.
Ueno H, Nakayama M, Kojima S, Kusuhara K, Nagayoshi Y, Yamamuro M, Nishijima T, Usuku H, Kaikita K, Sumida H, Yamabe H, Sugiyama S, Yoshimura M, Ogawa H. Ueno H, et al. Among authors: yamamuro m. Heart Vessels. 2008 Jul;23(4):243-8. doi: 10.1007/s00380-007-1034-5. Epub 2008 Jul 23. Heart Vessels. 2008. PMID: 18649054
220 results